[Surgical treatment strategy for digestive system malignancies during the outbreak of COVID-19]

Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):180-183. doi: 10.3760/cma.j.cn112152-20200223-00117.
[Article in Chinese]

Abstract

The outbreak of COVID-19 occurred in Wuhan, Hubei province of China, at the end of 2019, and spread rapidly across the country. After the outbreak of this disease, the overwhelming majority of cities have launched the "first level response" and the regular diagnosis and treatment of cancer patients are greatly affected. The digestive systemic cancer is the most common malignancy. Most patients are diagnosed in the advanced stage with poor prognosis. The epidemic of COVID-19 poses new challenges to diagnosis and treatment of the patients with digestive system malignancies. Based on the fully understanding of the characteristics of digestive system tumors, we should change the treatment strategy and adopt more reasonable treatment strategy timely during the epidemic period to minimize the adverse effects of the epidemic of COVID-19 on the treatment.

2019年12月,新型冠状病毒肺炎疫情在湖北武汉发生,并迅速向全国蔓延。疫情发生后,各省市纷纷启动一级响应,肿瘤患者的正常诊治受到较大影响。消化系统恶性肿瘤是中国最常见的恶性肿瘤,大多数患者确诊时已处于中晚期,预后差。疫情期间,消化系统恶性肿瘤患者的诊治面临着巨大考验。在充分认识消化系统恶性肿瘤特点的基础上,疫情期间适时地转变治疗策略,采用更加合理的治疗方式,以最大程度降低疫情对消化系统恶性肿瘤患者的治疗造成的不良影响。.

Keywords: COVID-19; Diagnosis and treatment; Digestive system; Neoplasms.

MeSH terms

  • Betacoronavirus
  • COVID-19
  • China
  • Communicable Disease Control / methods
  • Coronavirus Infections* / epidemiology
  • Coronavirus* / pathogenicity
  • Cross Infection / prevention & control*
  • Digestive System Neoplasms / surgery*
  • Disease Outbreaks* / prevention & control
  • Humans
  • Pandemics / prevention & control*
  • Patient Care Planning*
  • Pneumonia, Viral* / epidemiology
  • Risk
  • SARS-CoV-2